Back

Redefined Strategies to generate Conditional miR-141/200c miRNA cluster Knockout mice to eliminate confounding neo cassettes

Verma, R.; Srivastava, R.; Yadav, S. K.; Cormier, M.-K.; Yee, S.-P.; Lowther, K.

2025-09-07 neuroscience
10.1101/2025.09.02.673774 bioRxiv
Show abstract

MicroRNAs (miRNAs) of the miR-200 family specifically miR-141 and miR-200c regulate neurogenesis, differentiation, and epithelial-mesenchymal transitions in development and several diseases including cancer and stroke. The STOCK Mirc13tm1Mtm /Mmjax mouse line, which targets the miR-141/200c cluster, was originally generated and described by Park et al. 2012 as a conditional "knockout-first" allele requiring a two-step breeding strategy: FLP recombination to excise lacZ/neo cassettes followed by Cre recombination to delete the floxed miRNA cluster (1). However, subsequent studies either bypassed this step and reported knockouts based on direct crosses with Cre mouse lines, leaving residual lacZ/neo sequences that may silence upstream elements or introduce transcriptional artifacts or rare studies used less efficient FLPe Deleter mice. Here, we present a detailed and refined strategy to conditional miR-141/200c knockouts mice using FLPo Deleter mice to efficiently eliminate lacZ/neo cassettes. Our approach not only confirmed complete deletion of miR-141 and miR-200c in various organs such olfactory bulbs and lungs where these miRNAs are robustly expressed using various approach such as genotyping qPCR validation and in situ hybridization but showed that without the use of FLPo deleter mice deletion of miR-141/200c cluster amy also lead to loss of several close proximity physiologically important genes such as ptpn6, phb2, atn1 and eno1. By restoring a clean floxed allele using FLPo deleter mice prior to Cre deletion, we establish a reliable and interpretable mouse model for dissecting the roles of the miR-141/200c cluster miRNA in various disease models.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 16%
10.9%
2
Molecular Brain
26 papers in training set
Top 0.1%
10.5%
3
Scientific Reports
3102 papers in training set
Top 5%
10.5%
4
Frontiers in Neuroscience
223 papers in training set
Top 0.6%
5.0%
5
Cells
232 papers in training set
Top 0.3%
4.5%
6
International Journal of Molecular Sciences
453 papers in training set
Top 2%
4.0%
7
Biochemical and Biophysical Research Communications
78 papers in training set
Top 0.2%
2.8%
8
iScience
1063 papers in training set
Top 11%
2.0%
50% of probability mass above
9
Molecular Neurobiology
50 papers in training set
Top 0.3%
1.9%
10
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.2%
1.8%
11
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 4%
1.8%
12
BMC Medical Genomics
36 papers in training set
Top 0.4%
1.7%
13
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.4%
1.5%
14
Biomedicines
66 papers in training set
Top 1%
1.3%
15
Human Molecular Genetics
130 papers in training set
Top 3%
1.0%
16
Biomolecules
95 papers in training set
Top 1%
1.0%
17
BioTechniques
24 papers in training set
Top 0.2%
0.9%
18
Neuroscience Letters
28 papers in training set
Top 0.8%
0.9%
19
Cell Reports Methods
141 papers in training set
Top 4%
0.9%
20
Open Biology
95 papers in training set
Top 2%
0.8%
21
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.7%
0.8%
22
Aging
69 papers in training set
Top 2%
0.8%
23
Epigenetics
43 papers in training set
Top 0.9%
0.8%
24
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 43%
0.8%
25
G3 Genes|Genomes|Genetics
351 papers in training set
Top 2%
0.8%
26
Neuroscience Bulletin
11 papers in training set
Top 0.7%
0.7%
27
Bioinformatics Advances
184 papers in training set
Top 5%
0.7%
28
Database
51 papers in training set
Top 1%
0.7%
29
Briefings in Bioinformatics
326 papers in training set
Top 7%
0.7%
30
The Journal of Steroid Biochemistry and Molecular Biology
10 papers in training set
Top 0.4%
0.7%